Mayo Clinic selects AI-based diagnostics company to join accelerator program

Mediwhale, a South Korean artificial intelligence-powered health diagnostics company, has been selected for the MedTech Accelerator, an entrepreneurial and business development program for healthcare companies put on by Rochester, Minn.-based Mayo Clinic and Tempe-based Arizona State University. 

The 12-month program will support Mediwhale in developing go-to-market plans and investment opportunities as the company looks to achieve FDA approval and expand into the U.S. market. 

The company uses deep-learning algorithms to predict disease risk through retinal scans. 

Currently, Mediwhale's scans focus on cardiovascular, aging, kidney and eye health. The eye program shows a minimum 96 percent accuracy, according to a March 21 Mediwhale news release shared with Becker's.

The MedTech Accelerator is the third active accelerator program Mediwhale has joined in the U.S.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like